Stockholm, October 10, 2011 — NASDAQ OMX (NASDAQ: NDAQ) announces that trading in EXINI Diagnostics AB (short name: EXINI) shares will commence today, October 10, on First North at NASDAQ OMX Stockholm. EXINI belongs to the Health Care sector. EXINI is the 11th company to be admitted to trading on First North in 2011, and the fourth company this year to move its listing from Aktietorget to First North.
Founded in 1999 and headquartered in Lund, Sweden, EXINI offers advanced solutions for medical decision support to hospitals worldwide. EXINI is working on products for the diagnosis of some of the most frequent endemic diseases such as coronary heart disease, cancer, dementia and Parkinson's disease. For more information see www.exini.com.
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We are pleased that EXINI chose to list at First North, one of Europe’s most liquid growth markets, where they will make a great addition to our healthcare sector. It is encouraging to see a continued strong inflow of companies to our First North market, and we welcome more companies to take advantage of the investor visibility and reach that we can offer.”
EXINI’s CEO, Magnus Aurell, commented, “Our move to First North is expected to increase the international investor awareness for EXINI and our shares, which sets the foundation for continued growth and expansion. EXINI operates in a market with tremendous potential, and as a leader in the field of diagnostic software we look forward to leveraging our NASDAQ OMX listing in order to build our brand both locally and internationally.”
EXINI Diagnostics has appointed Thenberg & Kinde Fondkommission AB as Certified Adviser.
NASDAQ OMX Media contact:
Carl Norell +46 (8) 405 66 39
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.